Amgen's revenue grows 8% and adjusted profit beats expectations

Amgen earned $6.45 per share in the third quarter on an adjusted basis, which leaves out some costs and gains. Analysts expected $5.91. Total revenues rose 8% to $10.4 billion, and the company says higher sales volumes drove its product sales growth.

The results

Q3 2026
+9.2%
Adj. earnings
+0.9%
Revenue
+3.7%
The stock
Adjusted earnings per share
Expected $5.91
$6.45
Revenue
Expected $10.27B
$10.37B

What the company expects

For full-year 2026, Amgen expects total revenues of $38.9 billion to $39.7 billion and adjusted earnings per share of $22.90 to $23.70, or $18.34 to $19.28 under standard accounting rules. It plans about $2.6 billion of capital spending and share buybacks of no more than $3.0 billion.
Results for Q3 2026, released on November 3, after the close. Expected: average of analysts' forecasts. Earnings per share under GAAP accounting rules: $7.08.

AI analysis

Nov 3
With TrueWallet Pro
What drove the quarter, what it changes for the stock, and what it does not say. Upgrade to Pro from the TrueWallet app.

The whole feed is waiting

Sign in to read every post and follow wallets.
Sign in